PharmiNews

The Directory of Pharma Companies and News

Genmab

Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. Founded in 1999, the company has two approved antibodies, DARZALEX® (daratumumab) for the treatment of certain multiple myeloma indications, and Arzerra® (ofatumumab) for the treatment of certain chronic lymphocytic leukemia indications. Daratumumab is in clinical development for additional multiple myeloma indications, other blood cancers, and solid tumors. A subcutaneous formulation of ofatumumab is in development for relapsing multiple sclerosis. Genmab also has a broad clinical and pre-clinical product pipeline. Genmab's technology base consists of validated and proprietary next generation antibody technologies - the DuoBody® platform for generation of bispecific antibodies, and the HexaBody® platform which creates effector function enhanced antibodies. The company intends to leverage these technologies to create opportunities for full or co-ownership of future products. Genmab has alliances with top tier pharmaceutical and biotechnology companies.
Category: Biotech
Category: Biotech

Genmab News

DateNews
2017-01-05Genmab Announces Studies of Daratumumab (DARZALEX®) in Combination with Nivolumab in Solid Tumors and Multiple Myeloma
2017-01-04Genmab to Present at the 35th Annual J.P. Morgan Healthcare Conference
2016-12-13European Commission Grants Marketing Authorization for Arzerra® (ofatumumab) in combination with Fludarabine and Cycloph...
2016-12-05Genmab's ASH 2016 Data Review Meeting
2016-12-01Genmab to Hold ASH 2016 Data Review Meeting
2016-11-10CHMP Issues Positive Opinion Recommending Arzerra® (ofatumumab) in Combination with Fludarabine and Cyclophosphamide for...
2016-11-10Genmab's 2016 Capital Markets Day
2016-11-08Genmab to Present at the Jefferies 2016 London Healthcare Conference
2016-11-03Genmab to Host Capital Markets Day
2016-11-03Genmab Announces Daratumumab and Ofatumumab Data to Be Included in 18 Presentations at American Society of Hematology An...
2016-09-06Genmab to Present at the 2016 Morgan Stanley Global Healthcare Conference
2016-08-25Data from Phase III CASTOR Study of Daratumumab Published in The New England Journal of Medicine
2016-08-03Genmab Appoints Board Observer
2016-05-31Genmab to Present at the Goldman Sachs 37th Annual Global Healthcare Conference
2016-05-20First Participants Dosed in Clinical Study with DuoBody® Product
2016-05-19Daratumumab and Ofatumumab Data to Be Presented at 21st Congress of EHA
2016-01-07Daratumumab Data Published in The Lancet Shows Encouraging Efficacy in Heavily Pretreated and Refractory Multiple Myelom...
2015-12-21Genmab Announces Completion of Agreement to Transfer Remaining Ofatumumab Rights
2015-12-15Genmab to Present at the 34th Annual J.P. Morgan Healthcare Conference
2015-12-08Genmab's 2015 R&D Update Live from Orlando
2015-12-01Genmab to Hold R&D Update on Company's Progress in 2015
2015-11-11Genmab to Present at the Jefferies Autumn 2015 Global Healthcare Conference
2015-09-09Genmab to Present at the 2015 Morgan Stanley Global Healthcare Conference
2015-08-27Data Published in The New England Journal of Medicine Shows Daratumumab Monotherapy Induced Durable Responses in Heavily...
2015-06-02Genmab to Present at the Goldman Sachs 36th Annual Global Healthcare Conference
2015-06-01Ofatumumab Included in Regulatory Submission to US Authorities from Gilead
2015-05-21Ofatumumab and Daratumumab Data to Be Presented at 20th Congress of EHA
2015-01-08Genmab to Present at the 33rd Annual J.P. Morgan Healthcare Conference
2014-12-03Genmab to Webcast Post-ASH Investor Seminar
2014-11-14Genmab to Present at the Jefferies 2014 Global Healthcare Conference
2014-11-06Genmab Announces Daratumumab and Ofatumumab Data to Be Presented at American Society of Hematology Annual Meeting (ASH)
2014-09-11Genmab to Present at the Bank of America Merrill Lynch Global Healthcare Conference 2014
2014-05-27Genmab to Present at the Jefferies 2014 Global Healthcare Conference
2014-05-22Multiple Daratumumab Abstracts to be Presented at EHA
2014-05-15Daratumumab Data to Be Presented at 2014 ASCO Annual Meeting
2014-01-09Genmab to Present at the 32nd Annual J.P. Morgan Healthcare Conference
2013-12-05Genmab to Webcast Post ASH Investor Seminar
Brought to you by PharmiWeb.com - Latest Jobs in Pharma
Brought to you by www.pharmiweb.com - Latest Jobs in Pharma.